Patent · US Active

Methods and devices for analyte collection, extraction, concentration, and detection for clinical applications

US11287426B2 · kind B2 · utility

17Cited by
30References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 2, 2016
Grant dateMar 29, 2022
Priority date
Expiry dateSep 2, 2036

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N33/56983
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

In various embodiments devices and methods for the detection and/or quantification of clinically relevant pathogens (e.g., bacteria, fungi, viruses, etc.) are provided. In certain embodiments the device comprises a lateral-flow assay that detects the bacterium at a concentration of less than about 6×106 cells/mL, less than about 3×106 cells/ml, less than about 1×106 CFU/mL, or less than about 50 μg/mL. In certain embodiments the device comprises an aqueous two-phase system (ATPS) comprising a mixed phase solution that separates into a first phase solution and a second phase solution; and a lateral-flow assay (LFA). In certain embodiments the device comprises a flow-through system comprising a concentration component comprising an aqueous two-phase system (ATPS) comprising a mixed phase solution that separates into a first phase solution and a second phase solution; and a detection component disposed beneath said concentration component.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.